相关实验视频
Updated: Sep 10, 2025

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
348
肥胖医学中的药物类药物:明智的选择,适当的选择
Sanjay Kalra1, Amandeep Singh2, Nitin Kapoor3
1Department of Endocrinology, Bharti Hospital, Karnal, India; University Centre for Research& Development, Chandigarh University, Mohali, India.
JPMA. The Journal of the Pakistan Medical Association
|August 25, 2025
概括
生物仿制药与仿制药之间的区别正在变得模糊, 一个新的框架可以根据各种因素选择最佳的抗肥胖药物.
科学领域:
- 内分泌药理学
- 药物开发
- 抗肥胖药物
背景情况:
- 生物类似药和仿制药的区别正在发展,特别是在基于的药物中.
- 原始的半胺是生物制药,而后来的版本是合成的仿制药.
- Tirzepatide是一种合成多,突出显示分子类型的转变.
研究的目的:
- 提出关于抗肥胖药物的知情决策框架.
- 解决生物类似药与仿制基药之间的模糊界限.
- 促进与药物选择有关的信息共享.
主要方法:
- 概念框架的发展.
- 药物特性分析 (生物类似与通用,合成).
- 影响药物选择的因素的审查.
主要成果:
- 术语"类似药物"可以包括生物类药物和基于的通用药物.
- 提出了一个全面的决策框架.
- 影响药物选择的关键因素包括批准状态,证据基础,经济和供应链.
结论:
- 需要一个结构化的方法来应对现代抗肥胖药物的复杂性.
- 除了纯粹的疗效之外,诸如供应链和成本等因素至关重要.
- 建议的框架有助于临床医生和患者选择合适的治疗方法.
相关概念视频
Oral Hypoglycemic Agents: Biguanides and Glitazones
291
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
291
Obesity
612
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
612
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
256
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
256
Bioequivalence: Overview
1.2K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.2K
Prescription, Nonprescription and Orphan Drugs
844
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
844
Pharmacokinetic Models: Comparison and Selection Criterion
149
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
149

